January 25, 2016 / 5:23 PM / 2 years ago

BUZZ-Valeant Pharmaceuticals International Inc: CEO says on road to recovery

** Canadian drugmaker's U.S.-listed shares up 6 pct at $93.72

** Ailing Chief Executive, Michael Pearson, said he was on road to recovery but was uncertain when he would return from medical leave

** Pearson's illness capped a tumultuous year for Valeant as investors turned up pressure for Canadian drugmaker to provide more detailed plan on how it will increase profits in 2016

** Company also said FDA had accepted marketing application filed by partner AstraZeneca Plc for brodalumab injection, to treat patients with moderate-to-severe plaque psoriasis

** Valeant's stock had fallen 29 pct in 2015

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below